BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 4602668)

  • 1. N,N-dimethyltryptamine--a possible relationship to schizophrenia?
    Wyatt RJ; Gillin JC; Kaplan J; Stillman R; Mandel L; Ahn HS; VandenHeuvel WJ; Walker RW
    Adv Biochem Psychopharmacol; 1974; 11(0):299-313. PubMed ID: 4602668
    [No Abstract]   [Full Text] [Related]  

  • 2. A possible mechanism for the antischizophrenic action of chlorpromazine: inhibition of the formation of dimethyltryptamine by chlorpromazine metabolites.
    Narasimhachari N; Lin RL
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):341-51. PubMed ID: 4527612
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of N,N-dimethyltryptamine to evoke tolerance in cats.
    Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ
    Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for the absence of amine-N-methylation and O-methylation in indolethylamines with methyltetrahydrofolic acid-dependent N-methyltransferase.
    Lin RL; Narasimhachari N
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):535-42. PubMed ID: 4527795
    [No Abstract]   [Full Text] [Related]  

  • 5. The significance of some biochemical abnormalities in schizophrenia.
    Rodnight R
    Acta Neurol (Napoli); 1975; 30(1):85-101. PubMed ID: 1063539
    [No Abstract]   [Full Text] [Related]  

  • 6. Disruption of conditioned avoidance behavior by n,n-dimethyltryptamine (DMT) and stereotype by beta-phenylethylamine (PEA): animal models of attentional defects in schizophrenia.
    Stoff DM; Moja EA; Gillin JC; Wyatt RJ
    J Psychiatr Res; 1978; 14(1-4):225-40. PubMed ID: 281530
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: Dimethyltryptamine and psychosis.
    Lancet; 1974 Jul; 2(7873):140-1. PubMed ID: 4135558
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential antagonism by metergoline of the behavioral effects of indolealkylamine and phenethylamine hallucinogens in the rat.
    Commissaris RL; Lyness WH; Moore KE; Rech RH
    J Pharmacol Exp Ther; 1981 Oct; 219(1):170-4. PubMed ID: 6793709
    [No Abstract]   [Full Text] [Related]  

  • 9. Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat.
    Kovacic B; Domino EF
    J Pharmacol Exp Ther; 1976 Jun; 197(3):495-502. PubMed ID: 1064726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacological agents and the cyclic AMP system of rat brain.
    Uzunov P; Weiss B
    Adv Cyclic Nucleotide Res; 1972; 1():435-53. PubMed ID: 4146714
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of iproniazid and tranylcypromine of the half-life of N,N-dimethyltryptamine in rat brain and liver.
    Wang Lu LJ; Domino E
    Biochem Pharmacol; 1976 Jul; 25(13):1521-7. PubMed ID: 1066131
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia.
    Gillin JC; Wyatt RJ
    Psychopharmacol Bull; 1976 Oct; 12(4):12-3. PubMed ID: 1067623
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular pharmacology of hallucinogens.
    Johnston VS; Bradley RJ
    Recent Adv Biol Psychiatry; 1968; 10():74-99. PubMed ID: 4872761
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of psychotomimetic drugs upon human chromosomes in tissue culture.
    Rendon OR
    Cellule; 1974; 70(2-3):331,333-58. PubMed ID: 4533950
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure activity relations of some indolealkylamines in comparison to phenethylamines on motor activity and acquisition of avoidance behavior.
    Vasko MR; Lutz MP; Domino EF
    Psychopharmacologia; 1974 Mar; 36(1):49-58. PubMed ID: 4525044
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical abnormalities associated with schizophrenia.
    Smythies JR
    Br J Psychiatry; 1975; Spec No 9():41-7. PubMed ID: 1102037
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose response and time course effects of N,N-dimethyltryptamine on disruption of rat shuttlebox avoidance.
    Stoff DM; Moja EA; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1977 Jun; 12(3):339-46. PubMed ID: 266950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of serotonin and related substances on single neurons in the brain.
    Bradley PB; Briggs I
    Adv Biochem Psychopharmacol; 1974; 10():159-66. PubMed ID: 4527120
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions of partial LSD analogs with behavioral disrupting effects of LSD and DMT in the rat.
    Kovacic B; Wang Lu LJ; Ruffing D; Domino EF
    Eur J Pharmacol; 1978 Jan; 47(1):37-44. PubMed ID: 271075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
    Narasimhachari N; Baumann P; Pak HS; Carpenter WT; Zocchi AF; Hokanson L; Fujimori M; Himwich HE
    Biol Psychiatry; 1974 Jun; 8(3):293-305. PubMed ID: 4527813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.